Bone Diseases Clinical Research Trials

Tucson : Novartis Investigative site

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Fayetteville : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Duarte : City of Hope Updated

COG D9902: A COG Soft Tissue Sarcoma Biology and Banking Protocol

San Luis Obispo : Coastal Medical Research Group, Inc.

Do You Suffer From Gout? If you are Male and 50 years of age or older, or Female, 55 years of age or older and postmenopausal for at least 2 years, have a history or presence of Gout, have a history of risk of heart events, have hyperuricemia and more than one attack of Gout, you may qualify!

San Luis Obispo : Coastal Medical Research Group, Inc.

Do You Suffer From Gout? If you are male, 18 year of age or older, or a female, 45 years of age or older, you may qualify!

Anaheim : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Los Angeles : Novartis Investigative site

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Aurora : Novartis Investigative site

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Boynton Beach : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Gainesville : Novartis Investigative site

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Chicago : Ruth M Rothstein CORE Center

Study of Bone Disease in Older HIV-infected Adults

Fort Wayne : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Overland Park : Pfizer Investigational Site Updated

Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.

Paducah : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Baltimore : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Bethesda : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Boston : Novartis Investigative site

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Detroit : Michigan Bone and Mineral Clinic, PC

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Springfield : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

New Hyde Park : Novartis Investigative Site

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Syracuse : Novartis Investigative Site

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

High Point : Research Site Updated

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Providence : Novartis Investigative site

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Dallas : Novartis Investigative site

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Fort Worth : Novartis Investigative Site

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Houston : Novartis Investigative site

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Waco : Novartis Investigative site

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Madison : Novartis Investigative site

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

Feldkirch N/A :

Velcade Consolidation Bone Study

Graz :

Velcade Consolidation Bone Study

Wien :

Velcade Consolidation Bone Study

Brno :

Velcade Consolidation Bone Study

Vejle :

Velcade Consolidation Bone Study

Hamburg :

Velcade Consolidation Bone Study